Umb Bank, N.A. Denali Therapeutics Inc. Transaction History
Umb Bank, N.A.
- $5.92 Billion
- Q1 2025
A detailed history of Umb Bank, N.A. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 416 shares of DNLI stock, worth $6,864. This represents 0.0% of its overall portfolio holdings.
Number of Shares
416
Previous 382
8.9%
Holding current value
$6,864
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DNLI
# of Institutions
242Shares Held
111MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$217 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$203 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$198 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$90.4 Million0.02% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$88.4 Million0.55% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.21B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...